Coherus Biosciences Inc (NASDAQ: CHRS) is -71.80% lower on its value in year-to-date trading and has touched a low of $0.94 and a high of $3.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CHRS stock was last observed hovering at around $0.99 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $0.94, the stock is -8.61% and -22.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.29 million and changing -5.16% at the moment leaves the stock -50.75% off its SMA200. CHRS registered -74.55% loss for a year compared to 6-month loss of -57.31%. The firm has a 50-day simple moving average (SMA 50) of $1.21372 and a 200-day simple moving average (SMA200) of $1.90678.
The stock witnessed a -27.76% gain in the last 1 month and extending the period to 3 months gives it a -47.83%, and is -12.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.65% over the week and 9.77% over the month.
Coherus Biosciences Inc (CHRS) has around 306 employees, a market worth around $108.19M and $308.13M in sales. Profit margin for the company is -9.52%. Distance from 52-week low is -0.28% and -76.40% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.96%).
with sales reaching $62.83M over the same period.The EPS is expected to grow by 114.65% this year, but quarterly earnings will post 3.10% year-over-year. Quarterly sales are estimated to shrink -24.00% in year-over-year returns.
Coherus Biosciences Inc (CHRS) Top Institutional Holders
183.0 institutions hold shares in Coherus Biosciences Inc (CHRS), with institutional investors hold 74.34% of the company’s shares. The shares outstanding are 112.22M, and float is at 110.58M with Short Float at 25.29%. Institutions hold 73.31% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.75 million shares valued at $20.33 million. The investor’s holdings represent 10.4236% of the CHRS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.6 million shares valued at $18.34 million to account for 9.4035 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 10.4 million shares representing 9.224% and valued at over $17.99 million, while TEMASEK HOLDINGS (PRIVATE) LTD holds 5.1608 of the shares totaling 5.82 million with a market value of $10.07 million.
Coherus Biosciences Inc (CHRS) Insider Activity
The most recent transaction is an insider sale by Lanfear Dennis M, the company’s President & CEO. SEC filings show that Lanfear Dennis M sold 223,100 shares of the company’s common stock on Nov 22 ’23 at a price of $2.02 per share for a total of $0.45 million. Following the sale, the insider now owns 0.73 million shares.
